20 years of Cure Parkinson's
We’re here for the cure! This year marks 20 years since Cure Parkinson’s was founded by four people living with Parkinson’s who felt that nobody was taking a cure seriously enough and that there was an urgent need for a focused approach to curative research...
Learn more
Over £124k raised for Cure Parkinson’s at 2023 TCS London Marathon
On Sunday 23 April, 44 Cure Parkinson’s supporters laced up their trainers for the 2023 TCS London Marathon, raising an incredible amount for our research. Despite the rain #TeamCure hit the streets of London for the grueling 26.2 mile route, running past some of the…
Simon Cooper – Fundraiser of the Year 2022
We were delighted to announce the winner of our 2022 Fundraiser of the Year award as the remarkable Simon Cooper! Simon was instrumental in nominating Lloyd’s syndicate AEGIS London as lead sponsor of Cure Parkinson’s Coast-to-Coast-to-Cure cycle challenge in 2019, and in 2022 organised a…
Movers & Shakers: six familiar faces host podcast about living with Parkinson’s
A group of six friends living with Parkinson’s – some or all of whom you may recognise – regularly host a podcast to raise awareness of the condition. Cure Parkinson’s Patron and Vicar of Dibley co-writer Paul Mayhew-Archer is joined by former BBC presenter and…
Cure3 2023 raises almost £700,000 in most successful edition to date
Cure Parkinson’s, in association with Bonhams and Artwise, is delighted to announce that the 2023 acclaimed selling art exhibition Cure3 has raised almost £700,000 making this the most successful edition of the project so far. All profits will go directly to support Cure Parkinson’s vital…
Payroll Giving Month 2023: how you can help your employees support the causes they care about
Cure Parkinson’s is pleased to announce that a large-scale phase 3 clinical trial of ambroxol, to determine whether the drug can slow the progression of Parkinson’s.